A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

The purpose of this trial is to study how well modafinil works in treating children with memory and attention problems caused by cancer treatment for a brain tumor. Modafinil may help improve memory, attention, and fatigue caused by cancer treatment.

Stanford is now accepting new patients for this trial. Please contact Peds Hem/Onc CRAs at 650-723-5535 for more information.

Investigator(s):

Intervention(s):

  • drug : modafinil
  • other : placebo

Phase: Phase 2

Eligibility

Ages Eligible For Study:

6 Years - 19 Years

External Links

Explore related trials

Contact information

Primary Contact:

Peds Hem/Onc CRAs 650-723-5535

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: